Obesity: Entrance door to Multimorbidity;Adipositas: Eintrittspforte zur Multimorbiditat

Wiener Medizinische Wochenschrift

Volumn 148, Issue 17, 1998, Pages 388-392

  Sailer, D ^a  

^a Diabeteszentrum Bad Neustadt a d Saale ^*  (Germany)

Author keywords

Fat distribution; Insulin resistance; Obestiy; Risk of obesity

Indexed keywords

BODY FAT; BREAST CANCER; CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; ENDOMETRIUM CANCER; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSTATE CANCER; REVIEW; BODY COMPOSITION; BODY MASS; CAUSE OF DEATH; FEMALE; MALE; MORTALITY; RISK FACTOR;

BODY COMPOSITION; BODY MASS INDEX; CAUSE OF DEATH; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS;

EID: 0031767758     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Alexander JK: Cardiac structure and function in obesity. Mediopgraphia 1991;13:9-12.
2. Assman G, Schulte H: Obesity and hyperlipemia: results from the Prospective Cardiovascular Münster (PROCAM) Study. In Assmann G (ed): Lipid metabolism disorders and coronary heart disease. München, MMV, 1993, pp 19-67.
3. Bonadonna RC, DeFronzo RA: Glucose metabolism in obesity and type II diabetes. In Björntorp P, Brodoff BN (eds): Obesity. Philadelphia, Lippincott, 1993, pp 474-501.
4. Colditz GA, Willett WC, Stampfer MR: Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990;132:501-513.
5. DeFronzo RA, Ferranini E: Insulin resistance. A multifacted syndrome responsible für NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardivascular disease. Diabetes Care 1991;14:173-194.
6. Deutsche Adipositas Gesellschaft: Richtlinien zur Therapie der Adipositas. Adipositas 1995;5:6-10.
7. Felber J-P: From obesity to diabetes. Pathophysiological considerations. Int J Obes 1992;16:937-952.
8. Kelson DT, Anderson JIJ, Naimark A, Walker AM, Meenan RF: Obesity and knee osteoarthritis. The Framingham Study. Ann Inn Med 1988;109:18-24.
9. Ferranini E, Buzziogoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357.
10. Frontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E: Hyperinsulinemia as a predictor of coronary heart disease mortality in a health population: the Paris Prospective Study, 15-years follow-up. Diabetologia 1991;34:356-361.
11. Garrow JS: Obesity and related diseases. Edinburg, Churchill Livingstone, 1988, pp 329.
12. Goto T, Onuma T, Takebe K, Kral JG: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes 1995;19:841-845.
13. Grundstein K, Wicox I, Yang TS, Gould Y, Hedner J: Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes 1993;17:533-540.
14. Hall JE, Brands MW, Hillebrandt DA, Mizelle HL: Obesity-associated hypertension: Hyperinsulinemia and renal mechanism. Hypertension 1992;19:45-55.
15. Hall JE, Summer RL, Brands MW, Keen H, Alonso-Galicia M: Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertens 1994;7:722-788.
16. Harris Peeples L, Carpentier JW, Israel RG, Barakat HA: Alterations in low-density lipoproteins in subjects with abdominal obesity. Metab 1989;38:1929-1036.
17. Hauner H, Petruschke T, Russ M, Röhrig K, Eckel J: Effects of tumor necrosis factor alpha (TNF-Alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in culture. Diabetologia 1995;38:764-771.
18. Hoffmeister H, Mensink GBM, Stolzenberg H: National trends in risk factors for cardiovascular disease in Germany. Prevent Med 1994;23:197-205.
19. Klip A, Tsakiridis T, Marette A, Ortiz P: Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 1994;8:43-53.
20. Krobot K, Hense HW, Cremer P, Eberle E, Keil U: Determinants of plasma fibrinogen: Relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Arterioscler Thrombosis 1992;12:780-788.
21. Krone W, Müller-Wieland D, Wirth A: Dyslipoproteinämie und metabolisches Syndrom. Fortschr Med 1993;110:645-648.
22. Landsberg L: Diet, obesity and hypertension: on hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986;236:1081-1090.
23. Lauer MS, Anderson KM, Kannel WB, Levy D: The impact of obesity on left ventricular mass and geometry. JAMA 1991;266:231-236.
24. Leahy JL, Bonner-Weir S, Weir GC: Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 1988;81:1407-1410.
25. Lew EA, Garfinkel L: Variation in mortality by weight among 750,000 men and women. J Chron Dis 1979;32:563-576.
26. Manson JE, Willett WC, Stampfer MJ: Body weight and mortality among women. N Engl J Med 1995;333:677-685.
27. Mitchell BD, Stern MP, Haffner SM: Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol 1990;131:423-433.
28. Must A, Jaques PF, Dallal GE, Bajema CJ, Dietz WH: Long-term morbidity of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-1363.
29. Nakajima T, Fujioka S, Tokunaga K, Matsuzawa Y, Tarui S: Correlation of intraabdominal fat and left ventricular performance in obesity. Am J Cardiol 1989;64:369-373.
30. Ostlund ED, Staten M, Kohrt WM, Schultz J, Malley M: The ration of waist-to-hip circumference, plasma insulin, and glucose tolerance as independent predictors of the HDL2-cholesterin level in older adults. N Engl J Med 1990;322:229-234.
31. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. N Engl J Med 1990;323:167-174.
32. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chron Dis 1978;31:201-206.
33. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1495-1607.
34. Sasson Z, Rasooly Y, Bhesania T, Rasooly I: Insulin resistance is an important determinant oft left ventricular mass in the obese. Circulation 1993;88:1431-1436.
35. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM: Visceral obesity and breast cancer risk. Cancer 1994;74:632-639.
36. Seidell JC, Andres R, Sorkin JD, Muller DC: The sagittal waist diameter and mortality in men: the Baltimore Longitudinal Study on aging. Int J Obes 1994;18:61-67.
37. Sjöström L: Impacts of body weight, body composition, and adipose tissue distribution on morbidity and mortality. In Stunkard AJ, Waddem TA (eds): Obesity: Theory and therapy. Raven, New York, 1993, pp 13-41.
38. Society of Actuaries: Build and blood pressure study. Vol 1. Society of Actuaries, Chicago, 1959.
39. Society of Actuaries and Assiociation of Life Insurance Medical Directors of America: Build Study. Society of Actuaries, Chicago, 1983.
40. Svedberg J, Strömblad G, Wirth A, Smith U, Björntorp P: Fatty acids of the rat regulate hepatic insulin clearance. J Clin Invest 1991;88:2054-2058.
41. Swanson CA, Potischman N, Wilbanks GD: Relationship of endometrial cancer risk to past and contemporary body size and body fat. Cancer Epid Biochem Prev 1993;2:321-327.
42. Vague P, Raccah D, Scelles V: Hyperfibrinolysis and the insulin resistance syndrome. Int J Obes 1995;19 (suppl 1): 11-15.
43. Wirth A, Krone W: Abdominale Adipositas, metabolisches Syndrom, Arteriosklerose und Mortalität. Dtsch Med Wschr 1993;118: 595-601.
44. Wolfram W: Fettsucht: Neubewertung des Risikos in Abhängigkeit vom relativen Körpergewicht, Lebensalter und Fettverteilung. Ernähr Umschau 1990;37:347-354.